Non-small cell lung cancer stage IV
RecruitingStudy on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression
Study on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression
- Disease:Non-small cell lung cancer stage IV
- Substances:CarboplatinCisplatin+2
Italy- Participants:18–64 years · 65+ years
- Substances:Carboplatin
- Sponsor:Centro Di Riferimento Oncologico Di Aviano












